Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.